METTL3 and gastric cancer: With the findings demonstrating that silencing of METTL3 repressed the development of GC by inhibiting m6A modification of MYC mRNA in GC cells, we attributed HBXIP silencing to induce the blockade of METTL3-mediated m6A modification of MYC mRNA and hence inhibit GC progression.